Q&A

  • A person smiles and poses for a professional photo.
    Image attribution tooltip
    Permission granted by Biolinq
    Image attribution tooltip
    Q&A

    Biolinq’s Jared Tangney on making CGMs unintimidating

    The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, which he hopes will be easier to use than other glucose monitors.

    By • Oct. 20, 2025
  • Professional photo of Que Dallara
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip
    Q&A

    Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnership

    Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in becoming a standalone firm.

    By • Sept. 25, 2025
  • Chris smiles and wears a brown jacket.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s new diabetes leader on latest sensors, partnerships and Type 2 coverage

    Ahead of the American Diabetes Association’s Scientific Sessions, Chris Scoggins said Abbott’s ambition is to be the most broadly connected diabetes tech company.

    By • June 12, 2025
  • Professional photo of Osagie Ebekozien
    Image attribution tooltip
    Permission granted by The American Diabetes Association
    Image attribution tooltip
    Q&A

    ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards

    Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.

    By • May 9, 2025
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip
    Q&A

    Dexcom COO on 15-day glucose sensor, Type 2 coverage

    Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and an FDA warning letter.

    By • March 25, 2025
  • HCA Healthcare's Dr. Thomas Payne wears a gray suit jacket and blue and burgundy striped bow tie, against a gray background.
    Image attribution tooltip
    Permission granted by HCA Healthcare
    Image attribution tooltip
    Q&A

    Why HCA is ‘all in’ on surgical robotics

    Thomas Payne, HCA Healthcare’s national medical director of robotics, explains how the largest U.S. health system is vetting a new crop of market entrants.

    By • March 24, 2025
  • A headshot of Field Medical CEO Steven Mickelsen.
    Image attribution tooltip
    Permission granted by Field Medical
    Image attribution tooltip
    Q&A

    Steven Mickelsen, Farapulse founder, eyes next frontier in pulsed field ablation

    Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool for ventricular tachycardia as CEO of startup Field Medical.

    By • March 4, 2025
  • Side view portrait of doctor and patient talking in a clinic setting.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A

    Why health systems should be ‘clear-eyed’ about business goals for AI tools

    Caroline Pearson, the executive director of the Peterson Health Technology Institute, discusses the institute’s new task force studying the financial, efficiency and workforce effects of AI products.

    By Emily Olsen • Feb. 10, 2025
  • Professional photo of Kolaleh Eskandanian.
    Image attribution tooltip
    Permission granted by Children's National Hospital
    Image attribution tooltip
    Q&A

    Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.

    Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children and infants.

    By • Jan. 2, 2025
  • CMR Surgical Co-founder and CMO Mark Slack stands with his arms crossed in front of a Versius robot.
    Image attribution tooltip
    Permission granted by CMR Surgical
    Image attribution tooltip

    Robots, AI and PFA: The top medtech Q&As of 2024

    From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to discuss this year. Check out MedTech Dive’s top Q&As of 2024.

    By • Dec. 20, 2024
  • CMR Surgical Co-founder and CMO Mark Slack stands with his arms crossed in front of a Versius robot.
    Image attribution tooltip
    Permission granted by CMR Surgical
    Image attribution tooltip
    Q&A

    How CMR Surgical is taking on robotics’ ‘800-pound gorilla’

    “I don't think a monopoly market is healthy,” said CMR co-founder Mark Slack, discussing robotic surgery pioneer Intuitive Surgical’s continuing dominance in the market.

    By • Dec. 3, 2024
  • Professional photo of Vicky Demas
    Image attribution tooltip
    Courtesy of Identifeye Health
    Image attribution tooltip

    Verily alum looks to improve access to retinal scans

    CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google’s sibling Verily and Grail.

    By • Nov. 21, 2024
  • A photo shows Insulet Chief Medical Officer Trang Ly
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip
    Q&A

    Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

    Automated insulin delivery for Type 2 patients can help change minds among physicians who have been reluctant to prescribe pump therapy, the chief medical officer said in an interview.

    By • Aug. 27, 2024
  • A person playing a guitar in front of a microphone holds up a phone with a blood glucose reading on it.
    Image attribution tooltip
    Courtesy of Ascensia Diabetes Care
    Image attribution tooltip
    Q&A

    Ascensia’s new head of CGM talks plans for a 365-day sensor

    Brian Hansen recently joined Ascensia, which markets Senseonics’ implantable glucose sensors. The current version lasts 180 days, but Senseonics is seeking FDA approval for a one-year sensor.

    By • Aug. 6, 2024
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip
    Q&A

    Tandem CMO shares Mobi feedback, expansion plans

    MedTech Dive caught up with Chief Medical Officer Jordan Pinsker to talk about early feedback on Tandem’s smallest insulin pump and what’s next for the device.

    By • July 29, 2024
  • Medtronic's Stacey Churchwell is pictured wearing a blue suit jacket and white shirt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip
    Q&A

    ‘Our next frontier is prediction’: Medtronic on AI and heart disease

    Stacey Churchwell, who leads the company’s cardiovascular diagnostics and services business, says artificial intelligence is reducing false positives in its insertable cardiac monitors, saving clinicians valuable time.

    By • July 22, 2024
  • A blue, wavy device resembles a thin sponge.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip
    Q&A

    J&J’s Nisha Johnson on Ethizia wound-sealing patch, biosurgery market

    With the recent launch of the hemostatic healing patch in Europe, J&J expects to lead the biosurgery and wound closure market. 

    By • May 28, 2024
  • A headshot of Jennifer Jones-McMeans, who is smiling in the photo. She is wearing an orange blouse and blue hoop earrings.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s Jennifer Jones-McMeans on treating PAD below the knee

    Jennifer Jones-McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved stent for the tough-to-treat condition in an interview with MedTech Dive.

    By • May 9, 2024
  • A headshot of Dr. Nadim Geloo
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott’s Nadim Geloo on Triclip’s US launch, Edwards competition

    The senior medical director for structural heart discussed the Triclip rollout, Edwards’ rival tricuspid treatment and Abbott’s aortic valve clinical trial.

    By • April 12, 2024
  • Professional photo of Aldo Denti
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip
    Q&A

    J&J’s Aldo Denti on digital technology in orthopedics

    The chairman of J&J subsidiary DePuy Synthes talked about how surgical robots and other technologies have contributed to procedures moving to outpatient facilities.

    By • Updated April 1, 2024
  • Professional photo of Katherine Truppi
    Image attribution tooltip
    Permission granted by Stryker
    Image attribution tooltip
    Q&A

    Stryker’s next head of joint replacement talks about new revision, robotics products

    Katherine Truppi will become president of Stryker’s joint replacement business on March 31 after more than 20 years at the company.

    By • March 22, 2024
  • An image of Abbott's electrophysiology chief medical officer Christopher Piorkowski, who is smiling and wearing a suit and tie.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation

    Christopher Piorkowski, chief medical officer for the electrophysiology business, talks about the high expectations for the new atrial fibrillation treatment.

    By • March 1, 2024
  • A headshot of Per Langoe, new CEO of GT Medical, wearing a suit jacket.
    Image attribution tooltip
    Permission granted by GT Medical Technologies
    Image attribution tooltip
    Q&A

    New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy

    Langoe, the former head of Palette Life Sciences, spoke about his plans to expand use of GT Medical’s cancer-fighting implant.

    By • Feb. 23, 2024
  • Portrait of Bill Hunter
    Image attribution tooltip
    Permission granted by Canary Medical
    Image attribution tooltip
    Q&A

    Canary CEO Bill Hunter talks smart knee implant progress, new heart device

    The company collaborated with Zimmer Biomet on its Persona IQ device, which is slated for a full market release this year. Canary is also working on an implantable monitor for heart failure patients.

    By • Feb. 15, 2024
  • A head shot of Grail CEO Bob Ragusa
    Image attribution tooltip
    Permission granted by Grail
    Image attribution tooltip

    Grail CEO predicts ‘transformative’ 2024 amid Illumina split

    The liquid biopsy maker, which Illumina plans to divest, said it has made progress on a PMA application with the FDA for its Galleri multi-cancer early detection test.

    By • Dec. 19, 2023